Page 10 - LabMedya - ENG - 08
P. 10

/labmedya


        10                                                                                HEALTH AND LABORATORY MAGAZINE
















        A POTENTIAL CURE FOR AUTISM:

        GENE THERAPY COULD TREAT

        PITT-HOPKINS SYNDROME




        A new study has shown that gene
        therapy may be able to prevent or

        reverse many deleterious effects of

        Pitt-Hopkins syndrome.




        New research from the    34.000 and 1 in 41.000.   The scientists, who pub-  the father. Pitt-Hopkins   – but it hasn’t yet been
        UNC Neuroscience Center   The disorder affects both   lished their findings in the   syndrome arises in a child   tested.
        lab of Ben Philpot, Ph.D.,   men and women and is not   journal eLife, created an   when one copy of the gene
        finds restoring lost gene   restricted to a single ethnic   experimental, gene-ther-  TCF4 is missing or mutat-  Philpot’s team, led by first
        activity prevents many   group.                   apy-like technique to    ed, resulting in an insuffi-  author Hyojin (Sally) Kim,
        disease signs in an animal                        restore the normal function   cient level of TCF4 protein.   Ph.D., a graduate student
        model of Pitt-Hopkins syn-  Pitt Hopkins syndrome is   of the gene-deficient in   Typically, this deletion or   in the Philpot lab during
        drome, a rare, single-gene   classified as an Autism   people with Pitt-Hopkins   mutation occurs spontane-  the study, developed a
        neurodevelopmental       Spectrum Disorder, and   syndrome. The medication   ously in the parental egg or   mouse model of Pitt-Hop-
        condition.               some people who have it   prevented the onset of   sperm cell prior to con-  kins syndrome in which the
                                 have been diagnosed with   disease indicators such   ception, or in the earliest   level of the mouse version
        Pitt-Hopkins syndrome is   Autism, ‘atypical’ autistic   as anxiety-like behavior,   stages of embryonic life   of TCF4 could be reliably
        a rare genetic condition   characteristics, and/or   memory impairments, and   following conception.  halved. This mouse model
        caused by a mutation in   Sensory Integration Dys-  abnormal gene expression                        showed many typical signs
        the TCF4 gene on chro-   function. Many researchers   patterns in afflicted brain   Only about 500 cases of   of the disorder. Restoring
        mosome 18. Pitt-Hopkins   believe that treating Pitt   cells in newborn mice that   the syndrome have been   the full activity of the gene
        syndrome is characterized   Hopkins syndrome will lead   would otherwise model the   reported worldwide since it   from the start of embryon-
        by developmental de-     to treatments for similar   syndrome.             was first described by Aus-  ic life fully prevented these
        lay, potential respiratory   disorders because of its                      tralian researchers in 1978.   signs. The researchers also
        concerns such as episodic   genetic link to autism and   “This first, proof-of-prin-  But no one knows the syn-  found evidence in these
        hyperventilation and/    other conditions.        ciple demonstration sug-  drome’s true prevalence;   initial experiments that
        or breath-holding while                           gests that restoring normal   some estimates suggest   gene activity needed to
        awake, recurrent seizures/  For the first time, research-  levels of the Pitt-Hopkins   that there could be more   be restored in essentially
        epilepsy, gastrointesti-  ers at the University of   syndrome gene is a viable   than 10.000 cases in the   all types of neurons to
        nal difficulties, a lack of   North Carolina School of   therapy for Pitt-Hopkins   United States alone.  prevent the emergence of
        speech, and distinctive   Medicine have shown that   syndrome, which otherwise                      Pitt-Hopkins signs.
        facial features. Children   postnatal gene therapy   has no specific treatment,”   Since TCF4 is a “tran-
        diagnosed with Pitt-Hop-  may be able to prevent or   said senior author Ben   scription factor” gene, a   Next, the researchers set
        kins syndrome often have   reverse many of the nega-  Philpot, Ph.D., Kenan Dis-  master switch that controls   up a proof-of-concept
        a happy and lively attitude   tive effects of Pitt-Hopkins   tinguished Professor of Cell   the activities of at least   experiment modeling a
        with frequent smiling and   syndrome, a rare genetic   Biology and Physiology at   hundreds of other genes,   real-world gene therapy
        laughing.                disorder. Severe develop-  the UNC School of Medi-  its disruption from the start   strategy. In engineered
                                 mental delay, intellectual   cine and associate director   of development leads to   mice in which roughly
        The prevalence of        disability, respiratory and   of the University of North   numerous developmental   half the expression of the
        Pitt-Hopkins syndrome    movement abnormali-      Carolina (UNC) Neurosci-  abnormalities. In principle,   mouse version of Tcf4 was
        in the general popula-   ties, anxiety, epilepsy, and   ence Center.       preventing those ab-     switched off, the research-
        tion is unclear. However,   moderate but distinctive                       normalities by restoring   ers used a virus-delivered
        some estimates place the   facial abnormalities are all   Most genes are inherited   normal TCF4 expression   enzyme to switch the
        frequency of Pitt-Hopkins   symptoms of this autism   in pairs, one copy from   as early as possible is the   missing expression back
        syndrome between 1 in    spectrum disorder.       the mother and one from   best treatment strategy   on again in neurons, just
   5   6   7   8   9   10   11   12   13   14   15